7 June 1990
COMMERCIAL ITEM DESCRIPTION
GRISEOFULVIN TABLETS, ULTRAMICROSIZE, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-G-37839 which is cancelled.
This Commercial Item Description covers Griseofulvin Tablets, Ultramicrosize, USP.
Shall be Griseofulvin Tablets, Ultramicrosize, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of pharmaceutical grade.
For Strength 1, each tablet shall contain 125 mg of Griseofulvin, within the applicable assay limits for the tablets.
For Strength 2, each tablet shall contain 250 mg of Griseofulvin, within the applicable assay limits for the tablets.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Bottle (BT).
For Size 1, one bottle containing 100 tablets, as specified, constitutes one unit.
For Size 2, one bottle containing 500 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business